Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News KALA BIO Inc KALA

Healthcare Biotechnology
KALA BIO, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of therapies for rare and severe diseases of the eye. The Company’s biologics-based investigational therapies utilize its proprietary mesenchymal stem cell secretome (MSC-S) platform. The Company’s product candidate, KPI-012, is a human MSC-S, which contains... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:KALA)

KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire 1 day ago

KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire November 12, 2024

KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

GlobeNewswire August 8, 2024

KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire August 6, 2024

KALA BIO Announces $12,500,000 Private Placement

GlobeNewswire June 27, 2024

KALA BIO to Present at Jefferies Global Healthcare Conference

GlobeNewswire May 29, 2024

KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire May 14, 2024

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire March 29, 2024

KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference

GlobeNewswire February 26, 2024
View More News ››

Opinion & Analysis (NDAQ:KALA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:KALA)

KALA Bio, Inc. (KALA): A Promising Biopharmaceutical Company

http://beyondspx.com/2024/07/31/kala-bio-inc-kala-a-promising-biopharmaceutical-company-focused-on-rare-eye-diseases/
MikeTester - August 2, 2024

KALA BIO Announces $12,500,000 Private Placement

News; $KALA KALA BIO Announces $12,500,000 Private PlacementARLINGTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ...
whytestocks - June 27, 2024

KALA..... Now if I had just held those 500 shares at $6

I coulda been a contendah ; )
Iseneschal - January 4, 2023

KALA..... Can't halt progress ; )

Scalped the cr*p out of this today.... LoL....No skiing for me today.... made a chit ton of dough today. Still in my robe....no breakfast...
Iseneschal - December 29, 2022

RE:KALA ..... It held and was halted and rallied

What a run !!
moosesdad - December 28, 2022

KALA .....unreal !!!!

How sweet is this? Now at congestion dating back to last May pre-reverse split I got lucky being a seller !!!!
Iseneschal - December 28, 2022
View more Bullboard ››

Equity Metals Corp

Equity Metals Corp

Equity Metals Corporation is engaged in the acquisition, exploration and development of mineral and diamond properties in ...
View More »